Cytokinetics ($CYTK) Insider Trading & Smart Money Activity
Cytokinetics, Incorporated ($CYTK) has 9 insider trades, 2 congress trades, 6 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($1.94M), net -$1.94M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$1.94M
- Congress trades (12 mo)
- 2
- 13F moves on file
- 6
- Analyst ratings on file
- 2
CYTK insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $528.45K | 1 / 0 | 1 / 5 |
| Q3 2026 | 0 | 2 · $729.97K | 1 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $686.43K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CYTK insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Blum Robert IPresident & CEO | Sell (Open-market sale) 10b5-1 | 7.50K sh | $471.60K | Read | ||||||
| Insider | Malik Fady IbrahamEVP Research & Development | Sell (Open-market sale) 10b5-1 | 3.50K sh | $214.83K | +0.4% | — | |||||
| Congress | Gilbert Ray Cisneros Jr. | Purchase | $1,001 - $15,000 | -6.5% | Read | ||||||
| Insider | Blum Robert IPresident & CEO | Sell (Open-market sale) 10b5-1 | 7.50K sh | $490.95K | -5.2% | — | |||||
| Insider | Malik Fady IbrahamEVP Research & Development | Sell (Open-market sale) 10b5-1 | 3.50K sh | $239.01K | -2.9% | — | |||||
| Congress | Gilbert Ray Cisneros Jr. | Purchase | $1,001 - $15,000 | +0.4% | -5.6% | — | |||||
| Analyst | UBS | Raises to buy | PT $115 | -1.9% | -10.2% | Read | |||||
| Insider | Sung LeeEVP, Chief Financial Officer | Sell (Option exercise) | 376 sh | -1.9% | -10.2% | — | |||||
| Insider | Sung LeeEVP, Chief Financial Officer | Buy (Option exercise) | 3.13K sh | $143.64K | -1.9% | -10.2% | — | ||||
| Analyst | Mizuho | Reiterates to buy | PT $118 | +5.0% | -0.6% | Read | |||||
| Insider | Malik Fady IbrahamEVP Research & Development | Sell (Option exercise) | 3.50K sh | +6.5% | +2.4% | — | |||||
| Insider | Malik Fady IbrahamEVP Research & Development | Buy (Option exercise) | 3.50K sh | $27.30K | +6.5% | +2.4% | — | ||||
| Insider | Robert BlumPresident & CEO | Sell (Open-market sale) 10b5-1 | 7.50K sh | $528.45K | +10.9% | +15.7% | — | ||||
| 13F | Woodline Partners | Reduced | -648K sh | $85.23M | +1.4% | -5.9% | — | ||||
| 13F | T. Rowe Price Investment Management | Reduced | -192.53K sh | $1.49B | +1.4% | -5.9% | — | ||||
| 13F | T. Rowe Price Investment Management | Reduced | -192.53K sh | $1.21B | +1.4% | -5.9% | — | ||||
| 13F | Avoro Capital Advisors | New | +3.33M sh | $283.97M | +1.4% | -5.9% | Read | ||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -57.50K sh | +5.9% | -8.6% | — | |||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -57.50K sh | +5.9% | -8.6% | — |
1W / 1M / 6M = how CYTK moved from the trade or filing date.
Insider trading in CYTK: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Blum Robert I | President & CEO | 2 | -$962.55K | Oct 12, 2026 | |
| Malik Fady Ibraham | EVP Research & Development | 4 | -$453.85K | Oct 6, 2026 | |
| Sung Lee | EVP, Chief Financial Officer | 2 | — | Jun 29, 2026 | |
| Robert Blum | President & CEO | 1 | -$528.45K | Jun 15, 2026 |
Members of Congress trading CYTK
Institutions moving CYTK (13F)
Analyst ratings on CYTK
Frequently asked questions
Are CYTK insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 5 open-market sales worth $1.94M, a net -$1.94M.
What is the latest insider trade in CYTK?
Blum Robert I, President & CEO filed a sell (open-market sale) of 7.50K sh worth $471.60K on Oct 12, 2026.
Which members of Congress traded CYTK?
2 disclosed trades by Gilbert Ray Cisneros Jr.. The latest was on Sep 29, 2026.
Which institutions changed their CYTK positions?
Recent 13F filers moving the stock include T. Rowe Price Investment Management, Dekabank Deutsche Girozentrale, Woodline Partners and Avoro Capital Advisors.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.